Quintiles tweaks Apple's ResearchKit for use in biopharma-sponsored trials

Quintiles ($Q) has made changes to Apple's ($AAPL) open-source ResearchKit framework. The CRO made the enhancements--the code for which it released on the GitHub repository--to make Apple's platform more suitable for the trials it oversees. "We want to be the leader when it comes to collaboration with technology giants such as Apple," a spokesperson for Quintiles told Outsourcing-Pharma.com. Article | More

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.